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Introduction
Thioredoxins (Trx) are a class of small multifunctional 12 kDa proteins that are present in all prokaryotic and eukaryotic organisms and are characterized by the redox active site Trp-CysGly-Pro-Cys. In the oxidized (inactive) form of Trx (Trx-S 2 ), the two cysteines at the active site form a disulfide that is reduced by thioredoxin reductase (TrxR) and NADPH, the thioredoxin system, to a dithiol (Trx-(SH) 2 ) (1,2) which can then act as a general protein disulfide reductase.
Mammalian cytosolic thioredoxin, originally identified for its ability to act as hydrogen donor for ribonucleotide reductase, has a variety of biological activities (1, 2) . It serves as a cofactor for methionine sulfoxide reductase, catalyzes reduction of protein disulfide bonds, participates in folding of proteins and protein stability, modulates the DNA binding activity of receptors and some transcription factors (3) (4) (5) (6) (7) , regulates apoptosis by direct interaction with signal-regulating kinase 1 (8) and protects cells against oxidative stress (9) (10) (11) . In addition to cytosolic Trx, cells contain another thioredoxin localized in mitochondria (Trx2) (12) .
Mitochondria are cellular organelles where vital functions, such as electron transfer and oxidative phosphorylation reside. However, accumulating evidence suggests that mitochondria, apart from acting as supplier of ATP in cells, also function as major players in regulation of cell death. This latter role of mitochondria cannot only be assigned to the consequences of their loss of function, but rather to their active participation in the cellular death processes. Apoptogenic proteins are present in the mitochondrial intermembrane space, such as cytochrome c (13, 14) and apoptosis inducing factor (15, 16) , which upon apoptotic stimuli can be released by a still unclear mechanism. The induction of the permeability transition pore (PTP) has been suggested as a model for cytochrome c release. The PTP is comprised of the voltage-dependent anion channel (VDAC) located in the outer mitochondrial membrane and the adenine nucleotide translocator in the inner membrane.
Opening of the PTP would allow water and solutes to enter, leading to the swelling of mitochondria and rupture of the outer membrane, thereby releasing the apoptogenic proteins from the mitochondrial intermembrane space. However, it has been reported that the proapoptotic proteins, Bak and Bax, from the Bcl-2 family, can bind to VDAC and stimulate its opening leading to cytochrome c release (17) . This model allows for the release of cytochrome c without the extreme morphological changes resulting from the previous model.
Apoptosis is a process that requires energy (ATP). Therefore, the levels of ATP can be a crucial determinant of whether the cell dies by apoptosis or necrosis, and therefore, the mitochondria can act as checkpoints in deciding the death pathway. Thus, when cells are depleted of ATP, they will undergo necrosis rather than apoptosis (18) (19) (20) . Induction of the PTP is followed by membrane permeability transition (MPT) and subsequent loss of the mitochondrial membrane potential. Several drugs have been shown to cause mitochondrial membrane potential loss, such as rotenone, an inhibitor of the mitochondrial complex I (21, 22) , and the topoisomerase II poison etoposide which at low concentrations (10 µM) primarily targets the nucleus, whereafter the death signal is forwarded to the mitochondria. At higher concentrations (50 µM), however, etoposide directly targets the mitochondria (23) .
In the present study, we characterize the human mitochondrial Trx2 and investigate its role in the regulation of mitochondrial membrane potential and cell death. We show that overexpression of Trx2 confers resistance towards etoposide induced cytotoxicity. In contrast, The GenBank sequence database at the National Center of Biotechnology Information was accessed via Internet World Wide Web (http://www2.ncbi.nlm.nih.gov/) and the Basic Local Alignment Search Tool (BLAST) was used to identify human EST encoded proteins homologous to the rat Trx2. Guided by homology, several EST sequences were aligned along with rat Trx2 and a contiguous sequence was deduced by merging overlapping ESTs. Based upon the sequence obtained from the ESTs, we designed the primers hTrx2F1 (5'-ATGGCTCAGCGACTTCTTC) and hTrx2R1 (5'-GGCAAGGGAACCAGGACTCATCC).
A human liver cDNA library was used as template and hTrx2 cDNA was amplified by PCR.
The product was cloned into the pGEMTeasy vector and sequenced.
Protein expression, purification and enzymatic activity of human Trx2
The C-terminal fragment of hTrx2 (amino acids 60-166, h∆Trx2) was amplified with the mM NaCl, 50 mM imidazole). The concentration of the purified protein was determined spectrophotometrically with the molar extinction coefficient 7210 M -1 cm -1 . Activity assays were performed as described earlier (12) .
Human Trx2 subcellular localization
To study the subcellular localization of Trx2 we used the pEGFP-N3 vector (Clontech). The
Trx2 cDNA (aa 1-166) was amplified with the primers Trx2EcoRI (5'-CGGAATTCATGGCTCAGCGACTTCTTCTG) and hTrx2BamHI-N3 (5'-GCTTGGGATCCAATCAGCTTCTTCAG). Also, the C-terminal fragment of Trx2 (aa 60-166), omitting the tentative mitochondrial translocation signal, was amplified with the primers ∆Trx2EcoRI (5-GAGGAATTCCATGACAACCTTTAATATC) and hTrx2BamHI-N3. The primers introduced an EcoRI site at the 5 end and a BamHI site at the 3 end. The PCR products and the pEGFP-N3 vector were digested with EcoRI and BamHI. hTrx2 and h∆Trx2
were ligated into the vector, upstream and in frame with the EGFP. T47D breast cancer cells grown on glass cover slips were transfected with 2 µg plasmid containing either the entire hTrx2 or the truncated form using lipofectin (Gibco BRL). As positive control, a fusion of EGFP with the mitochondrial translocation signal of cytochrome c oxidase was used (24) . 24
h after transfection, the cells were washed 3 times in cold PBS and fixed in PBS with 4%
formaldehyde for 30 min at room temperature.
Immunohistochemistry
Paraffin sections containing multiple human tissues (T1065, Lot: 9994A) were obtained from Dako (Copenhagen, Denmark). The sections were first deparaffinized with xylene and rehydrated through graded ethanol. Subsequently, the sections were subjected to microwave antigen retrieval treatment as described earlier by Shi et al. (25) . Endogenous peroxidase activity was blocked by treating the sections with 0.1% hydrogen peroxide in PBS for 20 min.
Sections were incubated with purified rabbit antiserum raised against Trx2 (dil. 1:250 in PBS containing 1% BSA and 0.3% Triton X-100) for 12-24 h. After several washes, the sections were incubated with biotinylated goat-anti-rabbit antiserum (dil. 1:300) and ABC-complex (Vector Labs., Burlingame, CA, USA) for 30 min each. Diaminobenzidine was used as a chromogen to visualize Trx2-immunoreactivity. The sections were dehydrated, mounted and visualized with a Nikon Microphot-FXA microscope.
Generation of stable cell lines overexpressing human Trx2.
We established cell lines overexpressing Trx2 using the pIRES system (Clontech).
hTrx2/pGEMTeasy was digested with EcoRI and Trx2 was removed and ligated into the pIRESneo vector. Human embryo kidney 293 cells (HEK-293) were transfected with 10 µg of the Trx2/pIRESneo construct. Two days after transfection, the cells were passaged and positive clones were selected using 0.5 or 1 mg/ml G418. Control cells were prepared by transfecting the empty pIRESneo and selected as above. Single colonies were picked and analyzed to confirm the overexpression of Trx2 by western blot.
To measure the in vivo redox status of Trx2, mitochondrial enriched fractions were prepared.
Cells from confluent 25 cm 2 flasks were trypsinized, collected by centrifugation and washed twice in STEI (0.25 M sucrose, 10 mM Tris-base pH 7.2, 2 mM EDTA and 0.1 mM PMSF).
The pellet was resuspended in 400 µl STEI and homogenized with a tight fit glass-glass homogenizer. The homogenized cells were transferred to a microfuge tube and 400 µl of STEI were added before centrifugation at 700 x g for 10 min to sediment nuclei and unbroken cells. 
Results

cDNA cloning, enzymatic activity and mitochondrial localization of human Trx2
In order to isolate the human Trx2 cDNA, the rat Trx2 sequence was used to screen for homologous EST sequences in the dbEST database using BLAST program. From these homologous sequences, one contiguous sequence was constructed and used for designing primers to amplify the hTrx2 cDNA from a human liver library. hTrx2 has the same characteristic features as the rTrx2, such as the presence of a tentative N-terminal mitochondrial signal (1-59 aa) and the absence of structural cysteines (Fig. 1A) .
The enzymatic activities of reduced and oxidized purified human recombinant Trx2 and Trx1
were compared in an insulin reduction assay. Both proteins, when reduced with DTT, showed similar activities (Fig. 1B) . However, upon oxidation, the activity of hTrx2 was not affected while the activity of hTrx1 was drastically reduced.
The mitochondrial localization of hTrx2 was confirmed using Trx2 and ∆Trx2 (lacking the mitochondrial localization signal) fusion proteins with EGFP. As shown in Figure 1C , transfection with the empty pEGFP-N3 vector (a) or with ∆Trx2-EGFP (c) resulted in a homogeneous distribution of the EGFP both in the cytoplasm and nucleus. When EGFP was fused to the mitochondrial translocation signal of cytochrome c oxidase, the localization pattern was different (b). The nucleus was not stained and the staining in the cytoplasm showed a grained pattern. A similar pattern was obtained when the cells were transfected with the hTrx2/pEGFP-N3 (d), indicating that hTrx2 is a mitochondrial protein.
Expression pattern of hTrx2 mRNA and protein
To estimate the expression level of hTrx2 mRNA in different tissues, we used a human RNA Master Blot from Clontech. The blot was hybridized with a hTrx2 cDNA probe as well as a probe for GAPDH. The values for hTrx2 were divided by the GAPDH values. The highest value (stomach) was set as 100. As shown in Fig. 2 , Trx2 is ubiquitously expressed with the highest expression found in stomach. High levels of Trx2 were also present in salivary and mammary gland, testis, ovary, liver, heart, spinal cord, adrenal gland, hippocampus, lung as well as in fetal liver, lung and kidney.
Using immunohistochemistry, immunoreactivity (IR) of Trx2 could be observed in several tissues (Fig. 3) . The immunohistochemical results corroborate the mRNA expression of Trx2 obtained from the Master Blot. In stomach, the tissue with the highest mRNA levels, strong staining could be seen in parietal cells in gastric glands (A). The surface and neck mucous cells stained only lightly. Strong staining was also evident in macrophages in the lamina propria whereas lymphocytes appeared non-labelled (A). In colon, some strongly labelled macrophages were seen whereas the epithelial cells were weakly labelled (B). In kidney, Trx2-IR could be seen in the tubules while the glomeruli were not stained (C). In heart, the majority of the cardiac muscle fibers (D) as well as the smooth muscle cells of arteries and veins were labelled; the endothelial cells, however, did not stain (E,F). In testis, primary spermatocytes (G) and Leydig cells (H) were labelled. In prostate, the stromal smooth muscle cells were clearly labelled but the epithelial cells did not exhibit Trx2-IR (I). All layers of adrenal cortex, except the transition zone between zona glomerulosa and fasciculata, were intensely immunoreactive for Trx2 while the adrenal medulla was not labelled (J). The follicular cells of the thyroid gland were strongly labelled; on the other hand, other cell types of thyroid gland however, were negative (K). A population of the cells of exocrine pancreas stained strongly while the rest of the cells exhibited only moderate to light staining (L).
Analysis of Trx2 stable cell lines
We isolated several colonies from HEK-293 cells that were stably transfected. Total cell extracts were prepared and analyzed by western blot. Two colonies (Trx2 1.1, Trx2 1.4) growing at 1 mg/ml G418 were selected for further experiments. As shown in Figure 4A , 
Sensitivity towards mitochondrial respiratory chain inhibitors.
Since the HEK-Trx2 cells were less sensitive than control cells to etoposide, which at high concentrations, has been shown to affect mitochondria directly, we continued by using different inhibitors that directly target mitochondria leading to cell death. Cells were treated with rotenone (inhibitor of complex I), TTFA (inhibitor of complex II) and antimycin A (inhibitor of complex III). Inhibition of complex II and III with TTFA and antimycin A respectively ( Fig. 6A and B) , did not reveal any significant differences in cytotoxicity between the control and HEK-Trx2 cells. Surprisingly, when treated with rotenone, the HEK-Trx2 cells were more sensitive than control cells (Fig. 6C) . Interestingly, rotenone seemed to protect cells from TTFA induced cell death as the combination of rotenone with TTFA was less lethal than TTFA alone in the control cells (Fig. 6A ). This suggests that TTFA needs the function of the respiratory chain for its cytotoxic effect since inhibition of complex I decreased the rate of cell death. However, the Trx2 cells remained as sensitive to rotenone and TTFA as to rotenone alone suggesting that the increased rotenone lethality in HEK-Trx2 cells is independent of a functional complex II (Fig. 6A) .
Expression of Trx2 increases the mitochondrial membrane potential
To elucidate whether changes in the mitochondrial membrane potential (∆Ψ m ) could be the Taken together, these results suggest that the higher ∆Ψ m observed in the HEK-Trx2 cells is due to the modulation of ATP synthase activity by Trx2.
In the chloroplast ATP synthase thiol modulation is possible due to a sequence motif of nine amino acids including two cysteines in the γ subunit of chloroplast F 1 (27). This amino acid segment is only found in higher plants (37) and green algae (38) , suggesting that only chlorophyll a + b plants are capable of this specific mechanism of thiol modulation. However, showed strong labeling for Trx2 (Huikko and Spyrou, manuscript in preparation). Trx2 is a ubiquitously expressed protein found in all human tissues examined. Is it possible that there exists a tissue/cell specific regulation of Trx2? Our results using rats fed with dexamethasone showed that Trx2 mRNA was only upregulated in specific regions (paraventricular nucleus of the hypothalamus and the reticular thalamic nucleus) in the brain while the cortex, the hippocampus and the amygdala were unaffected (41) .
In summary, all data mentioned above suggest that Trx2 plays an important role in mitochondria. Our current working model suggests that Trx2 has an anti-apoptotic function.
Decreased levels of Trx2 may result in increased ROS, higher apoptotic rates and slower 
